Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    WS02 - IASLC CT Screening Symposium: Forefront Advances in Lung Cancer Screening (Ticketed Session) (In-person Access Only)

    • 09:00 - 16:00
    • 8/05/2022
    • Location: Strauss 3
    • Not for CME Credit
    • Type: Workshop
    • Track: N/A
    • +

      WS02.09 - Key Elements for Successful Implementation of a National Screening Program - The Taiwan Experience

      09:15 - 09:25  |  Presenter: Pan Chyr Yang

      • Abstract

      Loading...

  • +

    ES04 - Current Status of Lung Cancer Screening Worldwide

    • 12:00 - 13:00
    • 8/07/2022
    • Location: Hall C1
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Early Detection and Screening
    • +

      ES04.05 - Lung Cancer Screening in Asia for Individuals Without a Smoking History

      12:15 - 12:27  |  Presenter: Pan Chyr Yang

      • Abstract

      Loading...

  • +

    EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • +

      EP08.01-028 - Overestimation with Cox HR - Cox-TEL-Adjusted Associations of PD-L1 Expression with Immune Checkpoint Inhibitor Survival Benefit in Lung Cancer

      Presenter: Emily Pei-Ying Lin

      • Abstract

      Loading...